Skip to main content

Table 4 Clinical and laboratory characteristics of ILD patients with and without bronchiectasis

From: Bronchiectasis as co morbidity with COPD or ILD: complex interactions and severe consequences

Variable

ILD without bronchiectasis

(n = 24)

ILD + bronchiectasis

(n = 10)

p value

Cough (%)

23(95.8)

10(100.0)

0.5

Expectoration (%)

21(87.5)

9 (90.0)

0.8

Dyspnea (%)

23(95.8)

10(100.0)

0.5

Chest pain (%)

11(45.8)

6(60.0)

0.4

Hemoptysis (%)*

4(16.7)

9(90.0)

 < 0.0001*

Fever (%)

3 (12.5)

0(0.0)

0.2

Wheezes (%)

18(75.0)

7(70.0)

0.7

Clubbing (%)

2(8.3)

0(0.0)

0.3

Tachypnea (%)

4(16.7)

2(20.0)

0.8

CRP(+ ve)

2(8.3)

0(0.0)

0.3

Random blood sugar

 -Non-diabetic

10(41.7)

5

0.5

 -diabetic

11(45.8)

5

 

 -Pre-diabetic

3(12.5)

0

 

 Impaired kidney function (%)

1)4.2)

1(10.0)

0.5

 Pulse

(beat/min)

83.9 ± 8.4

80.7 ± 9.7

0.3

 Systolic blood pressure (mmHg)

121.6 ± 13.4

121.2 ± 8.3

0.9

 Diastolic blood pressure

(mmHg)

77.9 ± 8.0

77.5 ± 7

0.9

 Total leucocyte count

( thousands/ c.mm)

7.7 ± 3.2

7.5 ± 1.8

0.8

 Hemoglobin

(g/dl)

13.1 ± 1.3

13.3 ± 1.1

0.8

 Platelets

)thousands/ c.mm)

246.9 ± 72.6

237.5 ± 27.5

0.7

 ESR(2nd h)

(mm/h)

29.7 ± 32.1

18.3 ± 20.1

0.3

 Serum albumin

(g/dl)

4 ± 0.5

4.1 ± 0.4

0.6

 PCO2

(mmHg)

46.5 ± 11.4

53.6 ± 4.8

0.1

 PO2

(mmHg)

71.9 ± 14.7

72.5 ± 12.2

0.9

 SaO2

(%)

91.1 ± 5.3

90.3 ± 7

0.7

 Positive sputum culture (%)

5(20.8)

7(70.0)

0.006*

  1. Significance is considered at ≤ 0.05